Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2023-01-05 2022-11-10
Drug Identification Number 02243835 02243835
Brand name ARGATROBAN ARGATROBAN
Common or Proper name ARGATROBAN ARGATROBAN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ARGATROBAN ARGATROBAN
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 2.5ML 1 LIVI 1LIVI
ATC code B01AE B01AE
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-11-01 2022-11-01
Actual start date
Estimated end date 2023-03-31 2023-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Health Canada has permitted Sandoz Canada the exceptional, temporary importation and sale of a foreign product to provide an alternative treatment option during this critical shortage period. For more details visit: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-shortages/list.html or contact Sandoz Canada Inc. Important information: France-labelled Arganova product is distributed via SHN (Specialty Health Network by Shoppers Drug Mart) and sold under product number 1101249 - Arganova 2.5mL Vial of 100mg/mL. Order of Arganova product should be sent directly to SHN by email at orders@sdmshn.ca. Health Canada has permitted Sandoz Canada the exceptional, temporary importation and sale of a foreign product to provide an alternative treatment option during this critical shortage period. For more details visit: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-shortages/list.html or contact Sandoz Canada Inc. Important information: Due to increase of demand, France-labelled Arganova product is currently distributed with restrictions but a replenishment is expected at the end of Dec-2022 and should allow the removal of the ordering restriction measure.
Health Canada comments